SYK Q2 2024 Earnings — Stryker Corporation Revenue & Financial Results | Market Cap Arena

SYKStryker Corporation

$138B

Q2 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$5.4B+8.5% YoY

Gross Profit

$3.3B61.3% margin

Operating Income

$1.2B21.4% margin

Net Income

$825M15.2% margin

EPS (Diluted)

$2.14

QoQ Revenue Growth

+3.4%

Cash Flow

Operating Cash Flow

$633M

Free Cash Flow

$481M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$39.1B

Total Liabilities

$19.4B

Stockholders' Equity

$19.8B

Cash & Equivalents

$1.9B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5.4B	$5.0B	+8.5%
Gross Profit	$3.3B	$3.0B	+9.4%
Operating Income	$1.2B	$1.1B	+8.8%
Net Income	$825M	$738M	+11.8%

Revenue Segments

MedSurg

$3.1B57%

Orthopaedics and Spine

$2.3B43%

Geographic Segments

United States

$4.0B75%

Non-US

$1.4B25%